IconOVir

Theolytics

The company develops oncolytic viral immunotherapies for patients with solid tumours.

Oncolytic virus therapies

This clinical-stage biotechnology company develops engineered oncolytic virus therapies for cancer patients to destroy tumours and stimulate the immune system.

KaliVir Immunotherapeutics

This company develops oncolytic viral immunotherapies for cancer patients using a proprietary platform to engineer viruses that target and kill solid tumours.

Oncorus

This company develops intravenous self-amplifying RNA medicines and viral immunotherapies for patients with solid tumours.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.

TILT Biotherapeutics

This company develops oncolytic viral immunotherapies to treat patients with solid tumours by enhancing immune system responses against cancer cells.

Vironexis

The company develops adeno-associated virus gene therapies to treat blood-based cancers and prevent solid tumour metastasis for patients with oncological and immune disorders.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.